Sum composition results

AbbreviationFormulaMassMain ClassSub Class
Galα1-4Galβ1-4Glcβ-Cer(d34:1)C52H97NO181023.670570Neutral glycosphingolipids [SP05]Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Galα1-4Galβ1-4Glcβ-Cer(d36:1)C54H101NO181051.701871Neutral glycosphingolipids [SP05]Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Galα1-4Galβ1-4Glcβ-Cer(d38:1)C56H105NO181079.733171Neutral glycosphingolipids [SP05]Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Galα1-4Galβ1-4Glcβ-Cer(d40:1)C58H109NO181107.764471Neutral glycosphingolipids [SP05]Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Galα1-4Galβ1-4Glcβ-Cer(d42:2)C60H111NO181133.780121Neutral glycosphingolipids [SP05]Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Galα1-4Galβ1-4Glcβ-Cer(d42:1)C60H113NO181135.795771Neutral glycosphingolipids [SP05]Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Galα1-4Galβ1-4Glcβ-Cer(d44:2)C62H115NO181161.811421Neutral glycosphingolipids [SP05]Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Galα1-4Galβ1-4Glcβ-Cer(d44:1)C62H117NO181163.827071Neutral glycosphingolipids [SP05]Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Galα1-3Galα1-4Galβ1-4Glcβ-Cer(d34:1)C58H107NO231185.723396Neutral glycosphingolipids [SP05]Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Galβ1-3Galα1-4Galβ1-4Glcβ-Cer(d34:1)C58H107NO231185.723396Neutral glycosphingolipids [SP05]Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Galα1-3Galα1-4Galβ1-4Glcβ-Cer(d36:1)C60H111NO231213.754696Neutral glycosphingolipids [SP05]Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Galβ1-3Galα1-4Galβ1-4Glcβ-Cer(d36:1)C60H111NO231213.754696Neutral glycosphingolipids [SP05]Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer(d34:1)C60H110N2O231226.749944Neutral glycosphingolipids [SP05]Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
GlcNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer(d34:1)C60H110N2O231226.749944Neutral glycosphingolipids [SP05]Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Galα1-3Galα1-4Galβ1-4Glcβ-Cer(d38:1)C62H115NO231241.785996Neutral glycosphingolipids [SP05]Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Galβ1-3Galα1-4Galβ1-4Glcβ-Cer(d38:1)C62H115NO231241.785996Neutral glycosphingolipids [SP05]Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer(d36:1)C62H114N2O231254.781245Neutral glycosphingolipids [SP05]Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
GlcNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer(d36:1)C62H114N2O231254.781245Neutral glycosphingolipids [SP05]Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Galα1-3Galα1-4Galβ1-4Glcβ-Cer(d40:1)C64H119NO231269.817296Neutral glycosphingolipids [SP05]Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Galβ1-3Galα1-4Galβ1-4Glcβ-Cer(d40:1)C64H119NO231269.817296Neutral glycosphingolipids [SP05]Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer(d38:1)C64H118N2O231282.812545Neutral glycosphingolipids [SP05]Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
GlcNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer(d38:1)C64H118N2O231282.812545Neutral glycosphingolipids [SP05]Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Galα1-3Galα1-4Galβ1-4Glcβ-Cer(d42:2)C66H121NO231295.832946Neutral glycosphingolipids [SP05]Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Galβ1-3Galα1-4Galβ1-4Glcβ-Cer(d42:2)C66H121NO231295.832946Neutral glycosphingolipids [SP05]Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Galα1-3Galα1-4Galβ1-4Glcβ-Cer(d42:1)C66H123NO231297.848596Neutral glycosphingolipids [SP05]Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Galβ1-3Galα1-4Galβ1-4Glcβ-Cer(d42:1)C66H123NO231297.848596Neutral glycosphingolipids [SP05]Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer(d40:1)C66H122N2O231310.843845Neutral glycosphingolipids [SP05]Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
GlcNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer(d40:1)C66H122N2O231310.843845Neutral glycosphingolipids [SP05]Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Galα1-3Galα1-4Galβ1-4Glcβ-Cer(d44:2)C68H125NO231323.864246Neutral glycosphingolipids [SP05]Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Galβ1-3Galα1-4Galβ1-4Glcβ-Cer(d44:2)C68H125NO231323.864246Neutral glycosphingolipids [SP05]Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Galα1-3Galα1-4Galβ1-4Glcβ-Cer(d44:1)C68H127NO231325.879896Neutral glycosphingolipids [SP05]Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Galβ1-3Galα1-4Galβ1-4Glcβ-Cer(d44:1)C68H127NO231325.879896Neutral glycosphingolipids [SP05]Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Fucα1-2Galα1-3Galα1-4Galβ1-4Glcβ-Cer(d34:1)C64H117NO271331.781306Neutral glycosphingolipids [SP05]Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer(d42:2)C68H124N2O231336.859495Neutral glycosphingolipids [SP05]Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
GlcNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer(d42:2)C68H124N2O231336.859495Neutral glycosphingolipids [SP05]Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer(d42:1)C68H126N2O231338.875145Neutral glycosphingolipids [SP05]Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
GlcNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer(d42:1)C68H126N2O231338.875145Neutral glycosphingolipids [SP05]Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Galα1-3Galα1-3Galα1-4Galβ1-4Glcβ-Cer(d34:1)C64H117NO281347.776221Neutral glycosphingolipids [SP05]Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Fucα1-2Galα1-3Galα1-4Galβ1-4Glcβ-Cer(d36:1)C66H121NO271359.812606Neutral glycosphingolipids [SP05]Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer(d44:2)C70H128N2O231364.890795Neutral glycosphingolipids [SP05]Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
GlcNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer(d44:2)C70H128N2O231364.890795Neutral glycosphingolipids [SP05]Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer(d44:1)C70H130N2O231366.906445Neutral glycosphingolipids [SP05]Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
GlcNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer(d44:1)C70H130N2O231366.906445Neutral glycosphingolipids [SP05]Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Galα1-3Galα1-3Galα1-4Galβ1-4Glcβ-Cer(d36:1)C66H121NO281375.807521Neutral glycosphingolipids [SP05]Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Fucα1-2Galα1-3Galα1-4Galβ1-4Glcβ-Cer(d38:1)C68H125NO271387.843906Neutral glycosphingolipids [SP05]Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Galα1-4GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer(d34:1)C66H120N2O281388.802770Neutral glycosphingolipids [SP05]Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Galβ1-3GalNAcβ1-3Galα1-4Galβ1-4Glcβ-Cer(d34:1)C66H120N2O281388.802770Neutral glycosphingolipids [SP05]Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Galβ1-3GalNAcβ1-4Galα1-4Galβ1-4Glcβ-Cer(d34:1)C66H120N2O281388.802770Neutral glycosphingolipids [SP05]Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
GalNAcβ1-3Galα1-3Galα1-4Galβ1-4Glcβ-Cer(d34:1)C66H120N2O281388.802770Neutral glycosphingolipids [SP05]Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]
Galα1-3Galα1-3Galα1-4Galβ1-4Glcβ-Cer(d38:1)C68H125NO281403.838821Neutral glycosphingolipids [SP05]Galalpha1-4Galbeta1-4Glc- (Globo series) [SP0502]

Showing page 1 of 7     Results:    1  2  3  4  5  Next  Last     Showing results 1 to 50 of 320